1. Home
  2. ASRT

as 03-28-2025 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

Founded: 1995 Country:
United States
United States
Employees: N/A City: LAKE FOREST
Market Cap: 78.3M IPO Year: 1997
Target Price: $3.08 AVG Volume (30 days): 411.3K
Analyst Decision: Strong Buy Number of Analysts: 3
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.23 EPS Growth: N/A
52 Week Low/High: $0.68 - $1.80 Next Earning Date: 03-12-2025
Revenue: $124,961,000 Revenue Growth: -17.83%
Revenue Growth (this year): 0.96% Revenue Growth (next year): 12.72%

ASRT Daily Stock ML Predictions

Share on Social Networks: